TOP2A and cancer: Additionally, TOP2A is a risk factor for poor survival and a reliable prognostic biomarker in different cancers to predict cancer progression and relapse (Guo et al. 2020; Kou et al. 2020; Schaefer-Klein et al. 2015; Chen et al. 2021).